Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 126 points (-0.8%) at 15,723 as of Friday, Jan. 31, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,087 issues advancing vs. 1,837 declining with 186 unchanged. The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.5%. A company within the industry that increased today was HCA Holdings ( HCA), up 1.2%. On the negative front, top decliners within the industry include Hanger ( HGR), down 14.3%, C.R. Bard ( BCR), down 2.5%, Intuitive Surgical ( ISRG), down 1.6%, CareFusion ( CFN), down 1.5% and Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.5%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Accuray ( ARAY) is one of the companies pushing the Health Services industry higher today. As of noon trading, Accuray is up $1.01 (10.9%) to $10.25 on heavy volume. Thus far, 5.9 million shares of Accuray exchanged hands as compared to its average daily volume of 970,100 shares. The stock has ranged in price between $10.00-$10.71 after having opened the day at $10.14 as compared to the previous trading day's close of $9.24. Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. Accuray has a market cap of $667.9 million and is part of the health care sector. Shares are up 2.5% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts who rate Accuray a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates Accuray as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally high debt management risk. Get the full Accuray Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.